Back to Journals » Vascular Health and Risk Management » Volume 13

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives

Total article views   HTML views PDF downloads Totals
10,450 Dovepress* 8,317+ 1,786 10,103
PubMed Central* 2,133 674 2,807
Totals 10,450 2,460 12,910
*Since 4 September 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar